| |
|
|
|
Infinity Pharmaceuti  
|
|
2 0.19 (0.1%) |
11-27 13:00 |
|
Open: |
1.81 |
Pre close: |
1.81 |
Target:
|
2.53
|
|
High: |
2.0001 |
Low: |
1.81 |
Resistance:
|
2.17
2.53
|
|
Volume: |
437,303 |
Market Cap: |
128M |
Support:
|
1.47
1.04
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.00
 |
MACD |
MACD(12,26):
|
0.23  |
|
MA(20): |
1.56 |
Signal(12,26,9): |
0.19 |
|
MA(100): |
1.17 |
Stochastic Oscillator |
%K(14,3):
|
78.55 |
|
MA(250): |
1.10 |
%D(3): |
83.21 |
|
Average Volume(K) |
3-Month: |
61871
|
52-Week |
High:
|
2.17 |
|
10-Days: |
145256 |
Low: |
0.60 |
|
RSI |
RSI(14):
|
67.35 |
Change(%): |
55.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.711 |
Return on Equity (ttm) |
-1839.3 |
Shares Out. (M) |
64.21 |
|
EPS Est. Current Year |
-0.920 |
Return on Assets (ttm) |
-46.9 |
Shares Float (M) |
39.64 |
|
EPS Est. Next Year |
-1.500 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.25 |
|
EPS Est. Next Quarter |
-0.200 |
Qtrly Rev. Growth |
44.6 |
% Held by Institutions |
48.75 |
|
Forward EPS |
-0.830 |
Gross Profit (p.s.) |
-0.489 |
Shares Short (K) |
294 |
|
Book Value (p.s.) |
-0.220 |
EBITDA (p.s.) |
-0.612 |
P/E |
-2.81 |
|
Sales Per Share |
0.025 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-9.09 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-36.10 |
P/S |
80.77 |
|
Operating Margin |
-2502.70 |
Levered Free Cash Flow
(M) |
-24.04 |
P/CF |
-3.56 |
|
|
|
|
|
|
